Title |
Vertical RAS pathway inhibition in pancreatic cancer drives therapeutically exploitable mitochondrial alterations |
|---|---|
Involved |
Philipp Hafner (Verfasser)
Steffen Johannes Keller (Verfasser) Xun Chen (Verfasser) Asma Alrawashdeh (Verfasser)
Huda Jumaa (Verfasser)
Friederike Inga Nollmann (Verfasser) Solène Besson (Verfasser) Judith Kemming (Verfasser) Oliver Gorka (Verfasser) Tonmoy Das (Verfasser) Bismark Appiah (Verfasser) Ariane Lehmann (Verfasser) Mujia Li (Verfasser) Bertram Bengsch (Verfasser) Robert Zeiser (Verfasser) Stefan Tholen (Verfasser) Oliver Schilling (Verfasser) Olaf Groß (Verfasser) Andreas Vlachos (Verfasser) Uwe Alexander Wittel (Verfasser) Dominik von Elverfeldt (Verfasser) Wilfried Reichardt (Verfasser) Melanie Börries (Verfasser) Andrieux Geoffroy (Verfasser) Stefan Fichtner-Feigl (Verfasser) Luciana Hannibal (Verfasser) Dietrich Alexander Ruess (Verfasser) |
Published |
Freiburg: Universität |
Extent |
Online-Ressource |
Language |
|
Country |
|
Topic |
|
DDC notation |
|
Persistent identifier |
urn:nbn:de:bsz:25-freidok-2764111 (URN) |
Further information |
Signal transduction and targeted therapy. - 11, 1 (2026) , 33, ISSN: 2059-3635 |
Record ID |
1387948873 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: